Spectral AI (MDAI) Stock Price, News & Analysis

Company Overview

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

Key Stats

• Today's Range: $1.57 to $1.76
• 50-Day Range: $1.34 to $2.22
• 52-Week Range: $0.82 to $3.25
• Volume: 278,284 shs
• Average Volume: 847,283 shs
• Market Capitalization: $31.60 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.75
• Consensus Rating: Buy

Spectral AI Stock Analysis - MarketRank™

Spectral AI scored higher than 47% of companies evaluated by MarketBeat, and ranked 567th out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Buy

Consensus Rating

Spectral AI has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Spectral AI has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Spectral AI are expected to decrease in the coming year, from ($0.48) to ($0.55) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Spectral AI is -2.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Spectral AI is -2.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

10.52% of the float of Spectral AI has been sold short.

Short Interest Ratio / Days to Cover

Spectral AI has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Spectral AI has recently increased by 1.74%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Spectral AI does not currently pay a dividend.

Dividend Growth

Spectral AI does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

10.52% of the float of Spectral AI has been sold short.

Short Interest Ratio / Days to Cover

Spectral AI has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Spectral AI has recently increased by 1.74%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.17

News Sentiment

Spectral AI has a news sentiment score of 0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Spectral AI this week, compared to 2 articles on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Spectral AI insiders have not sold or bought any company stock.

Percentage Held by Insiders

56.73% of the stock of Spectral AI is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

67.08% of the stock of Spectral AI is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MDAI Stock Analysis - Frequently Asked Questions

How have MDAI shares performed this year?

Spectral AI's stock was trading at $2.83 at the beginning of 2025. Since then, MDAI shares have decreased by 39.9% and is now trading at $1.70.
View the best growth stocks for 2025 here.

How were Spectral AI's earnings last quarter?

Spectral AI, Inc. (NASDAQ:MDAI) posted its earnings results on Monday, August, 12th. The company reported ($0.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.14) by $0.02. The company earned $7.48 million during the quarter, compared to the consensus estimate of $6 million.

Who are Spectral AI's major shareholders?

Spectral AI's top institutional investors include Avantax Planning Partners Inc. (1.24%), Renaissance Technologies LLC (0.52%), Shay Capital LLC (0.21%) and Jane Street Group LLC (0.17%).
View institutional ownership trends.

How do I buy shares of Spectral AI?

Shares of MDAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Spectral AI own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Spectral AI investors own include Advanced Micro Devices (AMD), Meta Platforms (META), NVIDIA (NVDA), Oracle (ORCL), CRISPR Therapeutics (CRSP), Intel (INTC) and Snowflake (SNOW).

Company Calendar

• Last Earnings: 8/12/2024
• Today: 3/22/2025
• Next Earnings (Estimated): 3/27/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:MDAI
• CIK: 1833498
• Web: rosecliffspac.com
• Phone: 212-492-3000
• Fax: N/A
• Employees: 83
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $4.75
• High Stock Price Target: $6.00
• Low Stock Price Target: $3.50
• Potential Upside/Downside: +179.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.65)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-20,850,000.00
• Net Margins: -40.78%
• Pretax Margin: -40.39%
• Return on Equity: N/A
• Return on Assets: -77.87%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.73
• Quick Ratio: 0.69

Sales & Book Value

• Annual Sales: $27.26 million
• Price / Sales: 1.16
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.10) per share
• Price / Book: -17.00

Miscellaneous

• Outstanding Shares: 18,588,000
• Free Float: 8,043,000
• Market Cap: $31.60 million
• Optionable: Not Optionable
• Beta: 0.43